Home » Topics » Regulatory » NMPA

NMPA
RSS

Cervarix approved in China

July 18, 2016

CFDA approves Roche's CINtec PLUS Cytology test

March 9, 2016

3SBio obtains IND clearance in China for PEG-irinotecan

March 7, 2016

Tapros approved for open-angle glaucoma and ocular hypertension in China

Aug. 26, 2015

CFDA approves phase I/II/III clinical trials of pirotinib

Aug. 14, 2015

China Food and Drug Administration accepts clinical trial application for sirotinib

July 16, 2015

Phase II trials of F-351 begin in China

June 12, 2015

Arteether amine maleate cleared to enter clinical studies in China

May 26, 2015

China FDA clears IND for development of DP-VPA through phase III for epilepsy

April 16, 2015

China approves Epidaza for peripheral T-cell lymphoma

Jan. 13, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...